Table 2.

ANOVA values comparing WT and KO mice performance within the T1R1, T1R2, T1R3, and T1R2 + T1R3 groups that performed above chance (50%) on the highest test concentration presented of each test stimulus

GroupGenotypeConcentrationGenotype × concentration
NaCl
    T1R1F(1,15) = 0.500, p = 0.490F(10,150) = 79.552, p < 0.001*F(10,150) = 0.556, p = 0.847
    T1R2F(1,9) = 0.874, p = 0.374F(10,90) = 72.379, p < 0.001*F(10,90) = 1.432, p = 0.179
    T1R3F(1,8) = 0.615, p = 0.455F(10,80) = 80.659, p < 0.001*F(10,80) = 1.080, p = 0.387
    T1R2 + T1R3F(1,14) = 0.770, p = 0.395F(10,140) = 85.761, p < 0.001*F(10,140) = 1.046, p = 0.408
MSG
    T1R1F(1,15) = 0.226, p = 0.642F(8,120) = 145.303, p < 0.001*F(8,120) = 0.436, p = 0.897
    T1R2F(1,9) = 0.001, p = 0.983F(7,63) = 56.069, p < 0.001*F(7,63) = 2.269, p = 0.040*
    T1R3F(1,8) = 0.979, p = 0.351F(7,56) = 33.064, p < 0.001*F(7,56) = 0.582, p = 0.768
    T1R2 + T1R3F(1,13) = 1.024, p = 0.330F(7,91) = 78.211, p < 0.001*F(7,91) = 1.473, p = 0.187
MSG + 100 μm amiloride + 2.5 mm IMP
    T1R1F(1,11) = 61.328, p < 0.001*F(8,88) = 7.199, p < 0.001*F(8,88) = 6.347, p < 0.001*
    T1R2F(1,9) = 6.310, p = 0.033*F(8,72) = 3.919, p < 0.001*F(8,72) = 1.673, p = 0.120
    T1R3F(1,6) = 57.047, p < 0.001*F(8,48) = 5.417, p < 0.001*F(8,48) = 2.358, p = 0.032*
    T1R2 + T1R3F(1,9) = 190.4, p < 0.001*F(8,72) = 5.515, p < 0.001*F(8,72) = 4.649, p < 0.001*
l-Lysine
    T1R1F(1,14) = 0.824, p = 0.379F(7,98) = 133.108, p < 0.001*F(7,98) = 0.902, p = 0.508
  • *Significant effects.